Success Story: NIW Approved for a Developmental Biology Researcher
Client’s Testimonial:
"Thank you so much for everything!”
On June 27th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Epigenomics Account Manager in the Field of Developmental Biology (Approval Notice).
General Field: Developmental Biology
Position at the Time of Case Filing: Epigenomics Account Manager
Country of Origin: Egypt
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: June 27th, 2026
Processing Time: 13 months, 11 days (Premium Processing Upgrade Requested)
Case Summary:
The client earned a Ph.D. in biomedical sciences and works in the field of developmental biology, with research centered on understanding the genetic, epigenetic, and molecular mechanisms that guide how germline stem cells develop into mature oocytes. By improving scientific understanding of these developmental processes, the client's work seeks to generate insights that may contribute to addressing fertility disorders, hereditary diseases, and broader reproductive health challenges.
Rather than relying on a single accomplishment, we demonstrated that the client was well positioned to advance this nationally important work through a combination of scholarly achievements and evidence of independent recognition. The client had authored 6 peer-reviewed journal articles and 1 preprint, including first-authored publications, with the body of work receiving 59 citations from other researchers. While citation numbers alone do not determine the outcome of an NIW petition, USCIS may view independent citation activity as evidence that other scientists have relied upon an applicant's findings in advancing their own research. We also highlighted that several of the client's publications ranked among the more highly cited papers in their field for their respective publication years, providing additional context for the influence of the research beyond raw citation totals.
The petition further established that the client's research had attracted meaningful institutional support. The client's studies had been funded through programs supported by the National Institutes of Health (NIH), the National Institute of General Medical Sciences (NIGMS), and Bioinformatics for Next Generation Sequencing (BiNGS). Rather than treating funding as an award in itself, we explained how this support reflected the alignment of the client's research with areas of scientific importance, particularly efforts to improve reproductive health, understand hereditary diseases, and advance biotechnology. We also documented that the client's work had been disseminated through respected scientific publications and that the client intended to continue contributing to the field through ongoing research and scholarly publication.
To further corroborate the client's expertise and the broader significance of the research, we submitted four recommendation letters from established experts in the field. These letters provided independent assessments of the originality of the client's research, its influence on developmental biology, and the client's ability to continue advancing work with national importance. Independent expert testimony helped place the scientific record into context and supported our broader presentation of the client's qualifications. One expert noted:
“It is imperative that she be allowed to carry out her research uninterrupted so that the United States is able to benefit fully from its value.”
After reviewing the additional evidence, USCIS approved the petition. We are honored to have assisted the client throughout this process and congratulate them on achieving this important immigration milestone.